Cargando…
Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
Despite remarkable progress in melanoma therapy, the exceptional heterogeneity of the disease has prevented the development of reliable companion biomarkers for the prediction or monitoring of therapy responses. Here, we show that difficulties in detecting blood-based markers, like circulating tumor...
Autores principales: | Gorges, Katharina, Wiltfang, Lisa, Gorges, Tobias M., Sartori, Alexander, Hildebrandt, Lina, Keller, Laura, Volkmer, Beate, Peine, Sven, Babayan, Anna, Moll, Ingrid, Schneider, Stefan W., Twarock, Sören, Mohr, Peter, Fischer, Jens W., Pantel, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896052/ https://www.ncbi.nlm.nih.gov/pubmed/31671846 http://dx.doi.org/10.3390/cancers11111685 |
Ejemplares similares
-
Biology, detection, and clinical implications of circulating tumor cells
por: Joosse, Simon A, et al.
Publicado: (2015) -
Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
por: Kuske, Andra, et al.
Publicado: (2016) -
Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients
por: Koch, Claudia, et al.
Publicado: (2020) -
Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer
por: Gorges, Tobias M., et al.
Publicado: (2016) -
Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer
por: Abdalla, Thaer S. A., et al.
Publicado: (2021)